Planta Med 2007; 73(2): 184-187
DOI: 10.1055/s-2006-957081
Letter
© Georg Thieme Verlag KG Stuttgart · New York

Petasiphenone, a Phenol Isolated from Cimicifuga Racemosa, in vitro Inhibits Proliferation of the Human Prostate Cancer Cell Line LNCaP

Hubertus Jarry1 , Stefan Stromeier2 , Wolfgang Wuttke1 , Adolf Nahrstedt2
  • 1Division of Clinical and Experimental Endocrinology, University of Göttingen, Göttingen, Germany
  • 2Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany
Further Information

Publication History

Received: August 28, 2006

Accepted: December 5, 2006

Publication Date:
13 February 2007 (online)

Preview

Abstract

Extracts of Cimicifuga racemosa (L.) Nutt. (syn.: Actaea racemosa L.) (CR) inhibit the proliferation of the human prostate cancer cell line LNCaP. Recently, the phenylpropanoid ester 3,4-dihydroxyphenacyl caffeate (petasiphenone, 1) was isolated from CR. This substance is a structural homologue to petasiphenol ([3-(3,4-dihydroxyphenyl)-2-oxopropyl caffeate]), a compound produced by Petasites japonicus Sieb. & Zucc. which inhibits the growth of various human leukemia cell lines. Because of the structural similarity, we examined whether 1 affects the proliferation of LNCaP cells and the secretion of prostate-specific antigen (PSA). Under basal conditions as well as under co-incubation with 10 nM estradiol [E2 or 1 nM dihydrotestosterone (DHT)], 1 dose-dependently inhibited proliferation of LNCaP cells while PSA release per cell was not altered. We report for the first time that a defined compound isolated from CR inhibits the growth of the human prostate cancer cells LNCaP.

References

Prof. Dr. Hubertus Jarry

Division of Clinical and Experimental Endocrinology

Department of Obstetrics and Gynaecology

University of Göttingen

Robert Koch-Strasse 40

37075 Göttingen

Germany

Phone: +49-551-396-522

Fax: +49-551-396-518

Email: hubjarry@med.uni-goettingen.de